Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk - FOX 42: Omaha News, Sports and Weather; kptm.com |

Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, Ireland, August 21, 2014 /PRNewswire/ --


Research and Markets (http://www.researchandmarkets.com/research/3zh3q8/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to function by using bio-identical hormones. 

The therapy contains estrogen and progesterone, and in some cases testosterone, to reduce symptoms of menopause. This replacement therapy may also protect against osteoporosis, reduce the risk of coronary heart disease, and may prevent or delay the onset of Alzheimer's disease. Replacement therapy can also increase the chance of developing more serious health complications such as blood clots, breast cancer, uterine cancer, and bowel cancer.

The analysts forecast the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period 2013-2018.

The Global Hormone Replacement Therapy market can be divided into three segments: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy. 


Key Topics Covered: 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Type of Therapy

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

18. Other Reports in this Series 

Companies Mentioned:

  • Actavis plc
  • Bayer AG
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Abbott Laboratories Ltd.
  • Amgen Inc.
  • ANI Pharmaceuticals Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • MylanLaboratories Inc.
  • Orion Corp.
  • QuatRx Pharmaceuticals Co.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.

For more information visit http://www.researchandmarkets.com/research/3zh3q8/global_hormone


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

General Information:
contact42@kptm.com
402-558-4200

News:
news42@kptm.com
Phone: 402-554-4282
Fax: 402-554-4279

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KPTM. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.